Literature DB >> 21147466

A pivotal role for CXCL12 signaling in HPV-mediated transformation of keratinocytes: clues to understanding HPV-pathogenesis in WHIM syndrome.

Ken Y C Chow1, Émilie Brotin, Youcef Ben Khalifa, Laetitia Carthagena, Sébastien Teissier, Anne Danckaert, Jean-Luc Galzi, Fernando Arenzana-Seisdedos, Françoise Thierry, Françoise Bachelerie.   

Abstract

The WHIM syndrome, which features high susceptibility to human papillomavirus (HPV) infection, is a rare immunodeficiency associated with autosomal dominant heterozygous mutations of the CXCR4 chemokine receptor. CXCL12 and its receptors, CXCR4 and CXCR7, are linked to tumorigenesis, and we reported that abnormal expression of CXCL12 in epidermal keratinocytes correlates with HPV infection. However, the HPV-related pathologies observed in WHIM patients remain mechanistically unexplained. We show that keratinocytes immortalized by oncogenic HPV16 or HPV18 upregulate CXCL12 and its receptors in a manner dependent upon expression of the viral proteins E6 and E7. Autocrine signaling activated by CXCL12-engagement of its receptors controls motility and survival of the infected cells. Strikingly, expression of a WHIM syndrome-related gain-of-function CXCR4 mutant confers transforming capacity to HPV18-immortalized keratinocytes. These results establish a pivotal role for CXCL12 signaling in HPV-mediated transformation and provide a mechanistic basis for understanding HPV pathogenesis in WHIM syndrome.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21147466     DOI: 10.1016/j.chom.2010.11.006

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  24 in total

1.  Single oral administration of the novel CXCR4 antagonist, KRH-3955, induces an efficient and long-lasting increase of white blood cell count in normal macaques, and prevents CD4 depletion in SHIV-infected macaques: a preliminary study.

Authors:  Tadashi Nakasone; Sei Kumakura; Michiko Yamamoto; Tsutomu Murakami; Naoki Yamamoto
Journal:  Med Microbiol Immunol       Date:  2012-07-08       Impact factor: 3.402

2.  Autocrine CCL3 and CCL4 induced by the oncoprotein LMP1 promote Epstein-Barr virus-triggered B cell proliferation.

Authors:  Shu-Chun Tsai; Sue-Jane Lin; Cheau-Jye Lin; Ya-Ching Chou; Jiun-Han Lin; Te-Huei Yeh; Mei-Ru Chen; Li-Min Huang; Meng-You Lu; Ya-Chi Huang; Huan-Yun Chen; Ching-Hwa Tsai
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

3.  CXCR4 in epidermal keratinocytes: crosstalk within the skin.

Authors:  Wendy B Bollag; William D Hill
Journal:  J Invest Dermatol       Date:  2013-11       Impact factor: 8.551

4.  Microparticles mediate human papillomavirus type 6 or 11 infection of human macrophages.

Authors:  Yuchun Cao; Chunlei Liu; Zhichao Gu; Yong Zhang; Yi Duan; Yi Zhang; Huafeng Zhang; Ke Tang; Bo Huang
Journal:  Cell Mol Immunol       Date:  2015-04-20       Impact factor: 11.530

Review 5.  Genetics on a WHIM.

Authors:  Omar Al Ustwani; Razelle Kurzrock; Meir Wetzler
Journal:  Br J Haematol       Date:  2013-09-20       Impact factor: 6.998

Review 6.  Multisystem multitasking by CXCL12 and its receptors CXCR4 and ACKR3.

Authors:  Philip M Murphy; Lauren Heusinkveld
Journal:  Cytokine       Date:  2018-02-15       Impact factor: 3.861

Review 7.  CXCR4: a virus's best friend?

Authors:  Kathleen L Arnolds; Juliet V Spencer
Journal:  Infect Genet Evol       Date:  2014-05-02       Impact factor: 3.342

8.  The CXCR4 mutations in WHIM syndrome impair the stability of the T-cell immunologic synapse.

Authors:  Marinos Kallikourdis; Anna Elisa Trovato; Fabio Anselmi; Adelaida Sarukhan; Giuliana Roselli; Laura Tassone; Raffaele Badolato; Antonella Viola
Journal:  Blood       Date:  2013-06-21       Impact factor: 22.113

9.  A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor.

Authors:  David H McDermott; Qian Liu; Daniel Velez; Lizbeeth Lopez; Sandra Anaya-O'Brien; Jean Ulrick; Nana Kwatemaa; Judy Starling; Thomas A Fleisher; Debra A Long Priel; Melissa A Merideth; Robert L Giuntoli; Moses O Evbuomwan; Patricia Littel; Martha M Marquesen; Dianne Hilligoss; Rosamma DeCastro; George J Grimes; Samuel T Hwang; Stefania Pittaluga; Katherine R Calvo; Pamela Stratton; Edward W Cowen; Douglas B Kuhns; Harry L Malech; Philip M Murphy
Journal:  Blood       Date:  2014-02-12       Impact factor: 22.113

10.  Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling.

Authors:  Johan A den Boon; Dohun Pyeon; Sophia S Wang; Mark Horswill; Mark Schiffman; Mark Sherman; Rosemary E Zuna; Zhishi Wang; Stephen M Hewitt; Rachel Pearson; Meghan Schott; Lisa Chung; Qiuling He; Paul Lambert; Joan Walker; Michael A Newton; Nicolas Wentzensen; Paul Ahlquist
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.